Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Feinberg

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|March 24, 2021
Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 VaccineMark B Feinberg
Pediatrics|December 2, 2009
Industry perspectives: ensuring vaccination of children and adolescents without financial barriersMark B Feinberg, Lance Gordon
Nature Immunology|March 5, 2002
T(S) cells and immune tolerance induction: a regulatory renaissance?Mark B Feinberg, Guido Silvestri
Science (New York, N.Y.)|November 18, 2017
Advancing dengue vaccine developmentMark B Feinberg, Rafi Ahmed
The Journal of Clinical Investigation|September 17, 2003
Turnover of lymphocytes and conceptual paradigms in HIV infectionGuido Silvestri, Mark B Feinberg
Nature Immunology|June 21, 2012
Born this way? Understanding the immunological basis of effective HIV controlMark B Feinberg, Rafi Ahmed
Current Opinion in HIV and AIDS|April 18, 2009
Probing the possibilities for T-cell-based AIDS vaccinesDavid A Garber, Mark B Feinberg
Expert Review of Vaccines|August 3, 2004
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccinesSilvija I Staprans, Mark B Feinberg
Nature Medicine|March 3, 2004
HIV escape: there and back againJohn D Altman, Mark B Feinberg
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2015
Robust and sustained immune activation in human Ebola virus infectionJudith N Mandl, Mark B Feinberg
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|March 24, 2021
Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 VaccineMark B Feinberg
Pediatrics|December 2, 2009
Industry perspectives: ensuring vaccination of children and adolescents without financial barriersMark B Feinberg, Lance Gordon
Nature Immunology|March 5, 2002
T(S) cells and immune tolerance induction: a regulatory renaissance?Mark B Feinberg, Guido Silvestri
Science (New York, N.Y.)|November 18, 2017
Advancing dengue vaccine developmentMark B Feinberg, Rafi Ahmed
The Journal of Clinical Investigation|September 17, 2003
Turnover of lymphocytes and conceptual paradigms in HIV infectionGuido Silvestri, Mark B Feinberg
Nature Immunology|June 21, 2012
Born this way? Understanding the immunological basis of effective HIV controlMark B Feinberg, Rafi Ahmed
Current Opinion in HIV and AIDS|April 18, 2009
Probing the possibilities for T-cell-based AIDS vaccinesDavid A Garber, Mark B Feinberg
Expert Review of Vaccines|August 3, 2004
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccinesSilvija I Staprans, Mark B Feinberg
Nature Medicine|March 3, 2004
HIV escape: there and back againJohn D Altman, Mark B Feinberg
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2015
Robust and sustained immune activation in human Ebola virus infectionJudith N Mandl, Mark B Feinberg
Pageof 6